Port Hueneme, Calif.-based Stellar Biotechnologies Inc. regained compliance with Nasdaq's $1 minimum bid listing requirement.
The Nasdaq stock market notified the biotechnology company that the closing bid price for Stellar's common shares had been at least $1 per share for a minimum of 10 consecutive business days — effectively complying with the requirement.
